Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Folia Health Launches “BRAVE-PWS” Study to Better Understand the Real-World Experience of Prader-Willi Syndrome Caregivers
-
Sprott Launches Rare Earths Ex-China ETF
-
Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas
-
STS Digital Becomes First Principal Derivatives Dealer, Integrated as Exchange Partner on BitGo’s Go Network
-
Rezolve Ai Appoints James House to Lead Reward, Strengthening Its Global AI-Powered Banking and Commerce Platform
-
General Fusion Appoints Wendy Kei to Its Board of Directors
-
Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners
-
Calidi Biotherapeutics Announces Participation in RedChip’s April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
-
La Rosa Holdings Acquires Remaining 49% Interest in Orlando Brokerage Generating Approximately $3.3 Million in Revenue for 2025
-
NY State Society of CPAs Announces Class of 2026 Emerging Leaders
-
Syndigo Introduces SynapseGo™, Bringing Agentic Workflows to Business Users Through Conversation
-
GGSM Commences Development of Luxury Villas Projects in Bali
-
MX and Primitive Partner to Launch AI-Native Growth Agents for Financial Institutions
-
Allbirds, Inc. Executes $50M Convertible Financing Facility Agreement; Announces Expansion into AI Compute Infrastructure
-
CCC Introduces Consumer Financing in CCC ONE® to Help Collision Repair Shops Capture More Work
-
Freshpet, Inc. to Report First Quarter 2026 Results on Wednesday, May 6, 2026
-
AI-enabled Pixel Value Reduction curbs energy use and extends video viewing by up to 22%
-
Onex Announces Renewal of Normal Course Issuer Bid
-
Cue Biopharma to Present New Preclinical Data on Lead Autoimmune and Inflammatory Disease Candidate CUE-401 at IMMUNOLOGY2026
-
First Commonwealth Financial Corporation Appoints Ryan L. Gorney as Executive Vice President and Chief Information Officer
-
One Drink, One Tree at The Human Bean on Earth Day
-
Beyond Air to Participate in the D. Boral Capital Global Conference 2026
-
Extendicare Announces April 2026 Dividend of C$0.0441 per Share
-
Strive Announces Increase to SATA Perpetual Preferred Stock Dividend Rate to 13.00% and Bitcoin Buy
-
Eco Innovation Group, Inc. (ECOX) Initiates Frankfurt Exchange Dual Listing Process and Advances European SAF Strategy
-
Sunrise Realty Trust Schedules Earnings Release and Conference Call for the First Quarter Ended March 31, 2026
-
Immutep Receives FDA Orphan Drug Designation for Eftilagimod Alfa in Soft Tissue Sarcoma
-
AI-Enabled Fertility Care and Longevity Provider ONTO Health Closes $20 Million Series funded by ARTIS and Humania
-
Volatus Aerospace Secures Multi-Year Training Contract with NATO-Allied Government
-
Kobo Resources Announces Closing of Non-Brokered Private Placement for Gross Proceeds of $5.5 Million and Engagement of Atrium Research
-
Tilray Brands Accelerates Next Phase of Global Growth and Market Leadership
-
CrownGuard Capital Closes $22MM Bridge Loan for Acquisition & Development of Luxury Beach House in Southern California
-
CrownGuard Capital Closes $22MM Bridge Loan for Acquisition & Development of Luxury Beach House in Southern California
-
DEEP SEA MINERALS CORP. APPOINTS ANTHONY ZELEN TO THE BOARD OF DIRECTORS
-
Knight to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference
-
Inside the Science: New White Paper Explores the Injection Set to Redefine the Treatment of Knee Osteoarthritis & Unlock Access to Non-Surgical Options for Patients on the NHS
-
Inside the Science: New White Paper Explores the Injection Set to Redefine the Treatment of Knee Osteoarthritis & Unlock Access to Non-Surgical Options for Patients on the NHS
-
Black Iron Announces Upsizing of LIFE Offering
-
Ridgepost Capital Schedules First Quarter 2026 Earnings Release for Thursday, May 7, 2026
-
BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy
-
TG Therapeutics Announces Completion of Enrollment for the Phase 3 Trial Evaluating Subcutaneous BRIUMVI
-
Clearmind Medicine Announces Positive Data Safety Monitoring Board Recommendation in ongoing CMND-100 clinical trial
-
POWELL MAX LIMITED ANNOUNCES 1-FOR-10 SHARE CONSOLIDATION EFFECTIVE APRIL 17, 2026
-
Bitdeer Announces March 2026 Production and Operations Update
-
Prelude Therapeutics Announces the Appointment of Charles Morris, M.D. as Chief Medical Officer
-
Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B
-
Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression
-
Plus Therapeutics Appoints Randy H. Goodman, PhD, MHA, as Vice President of Value Strategy & HEOR to Advance Market Access and Commercial Execution
-
TMGI Announces Completion of the Apache Creek Golf Club Acquisition, Expands Platform for Scalable Golf Operations and Tee-Time Technology Monetization
-
BBQ Chicken Salad Reminds Everyone That Hot Dads Eat Habit Salads

